Volex plc to acquire Kepler SignalTek Ltd

Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on 14 July 2026. The transaction carries a headline offer value of 89.4 million US dollars. Consideration for the deal is structured as a combination of cash and earn-out payments. This structure aligns the interests of the acquiring group with the future performance of the target company. Both entities operate within the British market, facilitating a domestic consolidation within the healthcare industry. The immediate completion of the deal suggests a streamlined regulatory process and mutual agreement on terms. Volex plc, a UK-listed entity, expands its portfolio through this acquisition of Kepler SignalTek Ltd. The deal represents a significant capital deployment for the buyer in the healthcare segment.

The transaction is now fully completed. No further regulatory approvals or conditions remain outstanding for this specific acquisition. The integration of Kepler SignalTek Ltd into Volex plc’s operations can proceed without delay. Stakeholders can expect the financial impacts of the 89.4 million US dollar deal to be reflected in future reporting periods. The cash and earn-out components will be settled according to the agreed schedule. This strategic move positions Volex plc to leverage Kepler SignalTek Ltd’s capabilities within the broader healthcare market. The deal marks a definitive step in the buyer’s growth strategy for the sector. All parties have fulfilled their immediate obligations under the acquisition agreement. The status remains finalised with no pending actions required from either side.